| Hans-Günter Meyer-Thompson | Naloxon
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What?
Indivior-Funded Study Suggests Opvee Outperforms Narcan. But at What?
Indivior PLC, the pharmaceutical company that manufactures the opioid overdose antidote Opvee (nalmefene), has published new research showing that its product performed favorably compared to naloxone, in simulations of overdose involving fentanyl and carfentanil.
A pre-proof was published in the journal Neuropharmacology on June 6. Three of the four authors work for Indivior, and the fourth works for a software simulation company but was paid by Indivior for this study. (Filter, USA, 11.06.2024)